Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
Anidulafungin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/12/2020
Anisomycin
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/02/2020
Anisotine
Potential treatment - theoretical effect Natural product Antiviral Oct/19/2020
Anthrarufin
Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020
anti-IL-1α mAbs
Potential treatment - pre-clinical evidence Experimental Other treatment Jun/08/2020
Anti-SARS-CoV-2 monobody clone 6b
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/18/2020
Anti-spike nanobody-IFN-β conjugated exosomes
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2022
anti-spike-S1 IgYs
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/03/2020
Antihistamines
Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/16/2021
Antipain
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
AOaV-1-SARS-CoV-2
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/24/2020
Apabetalone
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/18/2021
Apicidin
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Apilimod
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020
Apixaban
Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/10/2020
Aprepitant
Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/17/2020
Aprotinin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/30/2020
Aptamer-1
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Aptamer-2
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
AQ-13
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020